Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Silver Spike Investment Corp.

SSICNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$10.73
$0.14(1.27%)
U.S. Market opens in 17h 26m

Silver Spike Investment Corp. (SSIC) Stock Overview

Explore Silver Spike Investment Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap66.7M
P/E Ratio-30.52
EPS (TTM)$0.90
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$19.60

SSIC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Silver Spike Investment Corp. (SSIC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $19.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -30.52 and a market capitalization of 66.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-17.23%
1-Month Change
0.89%
3-Month Change
-10.47%
6-Month Change
-5.00%
Year-to-Date (YTD) Change
26.74%
1-Year Change
14.45%
3-Year Change
-23.32%
5-Year Change
-23.32%
All-Time (Max) Change
-23.32%

Contact Information

212 905 4920
660 Madison Avenue, New York City, NY, 10065

Company Facts

IPO DateFeb 4, 2022
CountryUS

Frequently Asked Questions